{"id":7497,"date":"2021-12-16T08:02:30","date_gmt":"2021-12-16T13:02:30","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/offre-speciale-albiglutide-cas-782500-75-8-traiter-le-diabete\/"},"modified":"2021-12-16T08:02:30","modified_gmt":"2021-12-16T13:02:30","slug":"offre-speciale-albiglutide-cas-782500-75-8-traiter-le-diabete","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/fr\/product\/offre-speciale-albiglutide-cas-782500-75-8-traiter-le-diabete\/","title":{"rendered":"Offre sp\u00e9ciale Albiglutide CAS 782500-75-8 traiter le diab\u00e8te"},"content":{"rendered":"<h2><strong>Offre sp\u00e9ciale Albiglutide CAS 782500-75-8 traiter le diab\u00e8te<\/strong><\/h2>\n<p>Nom du produit\u00a0: Albiglutide<br \/>\nS\u00e9quence\u00a0: H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala- Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-OH<br \/>\nSynonymes\u00a0: albiglutide\u00a0; Albugon\u00a0; Naliglutide\u00a0; 7-36-Glucagon-like peptide I (8-glycine) (humain), prot\u00e9ine de fusion avec le 7-36-glucagon-like peptide I (8-glycine) (humain) prot\u00e9ine de fusion avec le s\u00e9rum;Gsk 716155;Unii-5E7U48495e;7-36-Glucagon-likepeptide I [8-glycine] ( HuMan), prot\u00e9ine de fusion avec le 7-36-glucagon-like peptide I[8-glycine] (huMan) prot\u00e9ine de fusion avec le s\u00e9rum albuMin (huMan)\u00a0; Fragment d&#39;albiglutide<br \/>\nCAS\u00a0: 782500-75-8<br \/>\nMF\u00a0: C148H223N39O46<br \/>\nMW\u00a0: 3284.58792<br \/>\nEINECS\u00a0:<br \/>\nCat\u00e9gories de produits\u00a0: BPL<br \/>\nFichier Mol\u00a0: 782500-75-8.mol<\/p>\n<p>L&#39;albiglutide est approuv\u00e9 par la FDA pour le diab\u00e8te de type 2 (DM) et la prophylaxie des troubles du syst\u00e8me cardiovasculaire r\u00e9sultant du diab\u00e8te de type 2. Son dosage implique une titration pour r\u00e9duire les sympt\u00f4mes gastro-intestinaux, tels que les naus\u00e9es, la diarrh\u00e9e et les vomissements\u00a0: initier une injection sous-cutan\u00e9e quotidienne de 0,6 mg pendant 1 semaine\u00a0; augmenter jusqu&#39;\u00e0 la dose d&#39;entretien de 1,2 mg par jour\u00a0; et augmenter \u00e0 1,8 mg par jour, au besoin.<br \/>\n Le liraglutide est \u00e9galement approuv\u00e9 par la FDA en tant que Saxenda pour l&#39;ob\u00e9sit\u00e9 avec un indice de masse corporelle de 30 kg\/m2 <or 27kg\/m2 with the presence of at least 1 weight-related comorbid condition. Saxenda is initiated at 0.6 mg subcutaneous daily injection for 1 week, with weekly increments of 0.6 mg per day, until the maintenance dosage of 3 mg once daily is reached.3 If the patient misses a dose of liraglutide injection for more than 3 days, re-initiation at 0.6 mg is recommended to mitigate gastrointestinal (GI) symptoms. <strong>Fonction et application d&#39;Albiglutide CAS 782500-75-8 <\/strong><br \/>\nLe 15\u00a0avril\u00a02014, la Food and Drug Administration (FDA) des \u00c9tats-Unis a officiellement approuv\u00e9 la commercialisation du m\u00e9dicament contre le diab\u00e8te Albiglutide. Le m\u00e9dicament est le deuxi\u00e8me analogue du GLP-1 \u00e0 longue dur\u00e9e d&#39;action approuv\u00e9 pour agoniser le r\u00e9cepteur du GLP-1 et favoriser la s\u00e9cr\u00e9tion d&#39;insuline pour le traitement du diab\u00e8te de type 2.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nom du produit : Albiglutide<br \/>\nCAS : 782500-75-8<br \/>\nMF : C148H223N39O46<br \/>\nMW : 3284.58792<br \/>\nMol Dossier : 782500-75-8.mol<\/p>\n","protected":false},"featured_media":2206,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[],"product_tag":[2257],"class_list":{"0":"post-7497","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_tag-hot-sale-albiglutide-cas-782500-75-8-treat-for-diabetes-fr","7":"desktop-align-left","8":"tablet-align-left","9":"mobile-align-left","11":"first","12":"instock","13":"shipping-taxable","14":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product\/7497","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/comments?post=7497"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/media\/2206"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/media?parent=7497"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product_brand?post=7497"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product_cat?post=7497"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product_tag?post=7497"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}